Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 9:00 PM ET

Date/Time Source News Release
05/07/2025 08:00 AM EDT GlobeNewswire Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
03/20/2025 07:22 AM EDT GlobeNewswire Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
03/06/2025 08:30 AM EST ACCESS Newswire Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
01/10/2025 08:00 AM EST GlobeNewswire Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
11/25/2024 04:01 PM EST GlobeNewswire Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
11/15/2024 11:02 AM EST GlobeNewswire Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
11/15/2024 11:01 AM EST GlobeNewswire Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
11/06/2024 08:00 AM EST GlobeNewswire Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
10/31/2024 08:00 AM EDT GlobeNewswire Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 - The Liver Meeting® and Attendance at November Conferences
Page
  • 1

Additional News

As of June 7, 2025 • 9:00 PM ET

Date/Time Source News Release
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Barinthus Biotherapeutics plc American Depositary Shares
05/08/2025 11:55 AM EDT SeekingAlpha Barinthus Biotherapeutics GAAP EPS of -$0.49 misses by $0.12
03/20/2025 05:09 PM EDT SeekingAlpha Barinthus Biotherapeutics GAAP EPS of -$1.55 misses by $0.25, revenue of $14.97M
03/19/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, March 19th, 2025
03/19/2025 05:30 AM EDT US Earnings Reports Expected earnings - Barinthus Biotherapeutics plc American Depositary Shares
01/31/2025 12:00 PM EST Zacks Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why
11/08/2024 04:38 AM EST US Earnings Reports Expected earnings - Barinthus Biotherapeutics plc American Depositary Shares
11/06/2024 10:56 AM EST SeekingAlpha Barinthus Biotherapeutics GAAP EPS of -$0.21 beats by $0.24, revenue of $14.97M
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.